Table 4.
Summary of baseline pulmonary function test results of patients with lung lesions and autoimmune lymphoproliferative syndrome
| Number of Patients Tested | Mean Values | 95% CI | |
|---|---|---|---|
| FEV1, L/s | 15 | 2.94 | (2.17–3.71) |
| Percent predicted | 84.87 | (74.77–94.96) | |
| FVC, L/s | 15 | 3.51 | (2.52–4.50) |
| Percent predicted | 86.73 | (75.69–97.77) | |
| FEV1/FVC ratio | 15 | 0.86 | (0.81–0.91) |
| Total lung capacity, L | 14 | 4.96 | (3.72–6.19) |
| Percent predicted | 89.14 | (82.61–95.68) | |
| Residual volume, L | 14 | 1.29 | (0.91–1.67) |
| Percent predicted | 102.07 | (79.79–124.35) | |
| DlCO-corrected Hb | 15 | 23.06 | (18.01–28.12) |
| Percent predicted | 69.77 | (60.32–79.22) | |
| 6-minute walk distance, m | 11 | 539.82 | (486.32–593.32) |
| Prewalk saturation, % | 11 | 98 | (96.35–99.65) |
| Postwalk saturation, % | 11 | 95 | (90.67–99.33) |
Definition of abbreviations: CI = confidence interval; DlCO = diffusing capacity of the lung for carbon monoxide.